Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
ArnoC. Gutleb. (2011) Potential of In Vitro Methods for Mechanistic Studies of Particulate Matter–Induced Cardiopulmonary Toxicity. Critical Reviews in Environmental Science and Technology 41:22, pages 1971-2002.
Read now
Read now
Thomas Meyer, Katharina Stuerz, Elke Guenther, Mitsuhiro Edamura & Udo Kraushaar. (2010) Cardiac slices as a predictive tool for arrhythmogenic potential of drugs and chemicals. Expert Opinion on Drug Metabolism & Toxicology 6:12, pages 1461-1475.
Read now
Read now
Clemens Möller. (2010) Keeping the rhythm: hERG and beyond in cardiovascular safety pharmacology. Expert Review of Clinical Pharmacology 3:3, pages 321-329.
Read now
Read now
Icilio Cavero. (2009) Exploratory Safety Pharmacology: a new safety paradigm to de-risk drug candidates prior to selection for regulatory science investigations. Expert Opinion on Drug Safety 8:6, pages 627-647.
Read now
Read now
Articles from other publishers (28)
Tobias Bruegmann, Patrick M. Boyle & Franziska Schneider-Warme. 2023. Heart Rate and Rhythm. Heart Rate and Rhythm
359
374
.
Dongxin Xu, Jiaru Fang & Ning Hu. (2021) Multifunctional Cardiomyocyte-Based Biosensor for Electrophysiology-Mechanical Beating-Growth Viability Monitoring. Multifunctional Cardiomyocyte-Based Biosensor for Electrophysiology-Mechanical Beating-Growth Viability Monitoring.
Duong T. Nguyen, Matthew O’Hara, Cecilia Graneli, Ryan Hicks, Tasso Miliotis, Ann-Christin Nyström, Sara Hansson, Pia Davidsson, Li-Ming Gan, Maria Chiara Magnone, Magnus Althage & Sepideh Heydarkhan-Hagvall. (2018) Humanizing Miniature Hearts through 4-Flow Cannulation Perfusion Decellularization and Recellularization. Scientific Reports 8:1.
Crossref
Crossref
Susanne Rehnelt, Daniela Malan, Krisztina Juhasz, Benjamin Wolters, Leo Doerr, Matthias Beckler, Ralf Kettenhofen, Heribert Bohlen, Tobias Bruegmann & Philipp Sasse. (2017) Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation. International Journal of Molecular Sciences 18:12, pages 2634.
Crossref
Crossref
Hendrik Lapp, Tobias Bruegmann, Daniela Malan, Stephanie Friedrichs, Carsten Kilgus, Alexandra Heidsieck & Philipp Sasse. (2017) Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes. Scientific Reports 7:1.
Crossref
Crossref
Alexandra Eder, Ingra Vollert, Arne Hansen & Thomas Eschenhagen. (2016) Human engineered heart tissue as a model system for drug testing. Advanced Drug Delivery Reviews 96, pages 214-224.
Crossref
Crossref
N. Hu, J. Fang, H. Li, K. Su & P. Wang. (2015) Dual-function microelectrode array system for simultaneously monitoring electromechanical integration status of cardiomyocytes. Dual-function microelectrode array system for simultaneously monitoring electromechanical integration status of cardiomyocytes.
Ning Hu, Tianxing Wang, Qin Wang, Jie Zhou, Ling Zou, Kaiqi Su, Jieying Wu & Ping Wang. (2015) High-performance beating pattern function of human induced pluripotent stem cell-derived cardiomyocyte-based biosensors for hERG inhibition recognition. Biosensors and Bioelectronics 67, pages 146-153.
Crossref
Crossref
Tomohiko Ikeuchi, Wilfred Espulgar, Eiichi Shimizu, Masato Saito, Jong-Kook Lee, Xiaoming Dou, Yoshinori Yamaguchi & Eiichi Tamiya. (2015) Optical microscopy imaging for the diagnosis of the pharmacological reaction of mouse embryonic stem cell-derived cardiomyocytes (mESC-CMs). The Analyst 140:19, pages 6500-6507.
Crossref
Crossref
Jordi Heijman & Dobromir Dobrev. (2014) Rat engineered heart tissue: a novel tool in the safety pharmacology toolkit?. Basic Research in Cardiology 109:6.
Crossref
Crossref
Jordi Heijman, Niels Voigt, Leif G Carlsson & Dobromir Dobrev. (2014) Cardiac safety assays. Current Opinion in Pharmacology 15, pages 16-21.
Crossref
Crossref
Vaibhav Shinde, Umesh Chaudhari, Isaia Sotiriadou, Jürgen Hescheler & Agapios Sachinidis. 2014. In Vitro Toxicology Systems. In Vitro Toxicology Systems
45
77
.
Sreejit ParameswaranSujeet KumarRama Shanker VermaRajendra K. Sharma. (2013) Cardiomyocyte culture — an update on the in vitro cardiovascular model and future challenges. Canadian Journal of Physiology and Pharmacology 91:12, pages 985-998.
Crossref
Crossref
SV Malysheva, HV Budash, NM Bil'ko & J Heschheller. (2013) Cardiomyocyte differentiation of individual clones murine induced pluripotent stem cells. Fiziolohichnyĭ zhurnal 59:3, pages 10-17.
Crossref
Crossref
Carl‐Fredrik Mandenius & Thomas Meyer. 2013. High‐Throughput Screening Methods in Toxicity Testing. High‐Throughput Screening Methods in Toxicity Testing
403
420
.
Andreas W. Daus, Paul G. Layer & Christiane Thielemann. (2012) A spheroid-based biosensor for the label-free detection of drug-induced field potential alterations. Sensors and Actuators B: Chemical 165:1, pages 53-58.
Crossref
Crossref
Qingjun Liu, Hui Yu, Zhou Tan, Hua Cai, Weiwei Ye, Ming Zhang & Ping Wang. (2011) In vitro assessing the risk of drug-induced cardiotoxicity by embryonic stem cell-based biosensor. Sensors and Actuators B: Chemical 155:1, pages 214-219.
Crossref
Crossref
Chunhui Xu, Shailaja Police, Mohammad Hassanipour, Yan Li, Yinhong Chen, Catherine Priest, Chris O’Sullivan, Michael A Laflamme, Wei-Zhong Zhu, Benjamin Van Biber, Livia Hegerova, Jiwei Yang, Karen Delavan-Boorsma, Anthony Davies, Jane Lebkowski & Joseph D Gold. (2011) Efficient generation and cryopreservation of cardiomyocytes derived from human embryonic stem cells. Regenerative Medicine 6:1, pages 53-66.
Crossref
Crossref
Attila S. Farkas & Stanley Nattel. (2010) Minimizing Repolarization-Related Proarrhythmic Risk in Drug Development and Clinical Practice. Drugs 70:5, pages 573-603.
Crossref
Crossref
Hilmar Vidarsson, Johan Hyllner & Peter Sartipy. (2010) Differentiation of Human Embryonic Stem Cells to Cardiomyocytes for In Vitro and In Vivo Applications. Stem Cell Reviews and Reports 6:1, pages 108-120.
Crossref
Crossref
Eric R. Fedyk. 2009. Enzyme Inhibition in Drug Discovery and Development. Enzyme Inhibition in Drug Discovery and Development
71
90
.
Tina C. Stummann, Mario Beilmann, Göran Duker, Berengere Dumotier, J. Magnus Fredriksson, Robin L. Jones, Marina Hasiwa, Y. James Kang, Carl-Fredrik Mandenius, Thomas Meyer, Giorgio Minotti, Y. Jean-Pierre Valentin, Bernd J. Zünkler & Susanne Bremer. (2009) Report and Recommendations of the Workshop of the European Centre for the Validation of Alternative Methods for Drug-Induced Cardiotoxicity. Cardiovascular Toxicology 9:3, pages 107-125.
Crossref
Crossref
Jacques Hamon & Steven Whitebread. 2009. Hit and Lead Profiling. Hit and Lead Profiling
273
295
.
Jacques HamonSteven Whitebread, Valerie Techer-EtienneHelene Le CoqKamal AzzaouiLaszlo Urban. (2009)
In vitro
safety pharmacology profiling: what else beyond hERG?
. Future Medicinal Chemistry 1:4, pages 645-665.
Crossref
Crossref
Catharina Ellerström, Petter Björquist, Peter Sartipy, Johan Hyllner & Raimund Strehl. 2009. Emerging Technology Platforms for Stem Cells. Emerging Technology Platforms for Stem Cells
417
437
.
Su Jung ParkKwan Seok ChoiDong Hoon ShinJin Sook KimDae Sik JangJae Beom YoumHan ChoeYung E EarmSung Joon Kim. (2009) Effects of Mixed Herbal Extracts from Parched Puerariae Radix, Gingered Magnoliae Cortex, Glycyrrhizae Radix and Euphorbiae Radix (KIOM-79) on Cardiac Ion Channels and Action Potentials. Journal of Korean Medical Science 24:3, pages 403.
Crossref
Crossref
Robert Zweigerdt. 2009. Engineering of Stem Cells. Engineering of Stem Cells
201
235
.
Tina C. StummannMateusz WronskiTomasz SobanskiBenjamin KumpfmuellerLars HarengSusanne BremerMaurice P. Whelan. (2008) Digital Movie Analysis for Quantification of Beating Frequencies, Chronotropic Effects, and Beating Areas in Cardiomyocyte Cultures. ASSAY and Drug Development Technologies 6:3, pages 375-385.
Crossref
Crossref